This HTML5 document contains 184 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n18	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n11	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127517/price-of-originator/
n3	http://linked.opendata.cz/ontology/sukl/
n14	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127517/reimbursement/
n10	http://linked.opendata.cz/resource/sukl/specialization-restriction/
n7	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127517/
skos	http://www.w3.org/2004/02/skos/core#
n9	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127517/core-reimbursement/
n19	http://linked.opendata.cz/resource/sukl/indgroup/
n16	http://linked.opendata.cz/resource/sukl/packing/
n8	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127517/price/
n13	http://linked.opendata.cz/resource/sukl/company/
n17	http://linked.opendata.cz/resource/sukl/active-ingredient/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n15	http://linked.opendata.cz/resource/sukl/registration-state/
xsdh	http://www.w3.org/2001/XMLSchema#
n5	http://www.sukl.cz/modules/medication/
n12	http://linked.opendata.cz/resource/sukl/df/
n4	http://linked.opendata.cz/resource/atc/

Statements

Subject Item

n2:0127517

rdf:type

n3:MedicinalProductPackaging

dcterms:title

CEFTAZIDIM MYLAN 2 G

skos:notation

0127517

n3:hasATCCode

n4:J01DD02

n3:hasActiveIngredient

n17:CEFTAZIDIMUM-PENTAHYDRICUM

n3:hasDefinedDailyDose

n7:ddd

n3:hasDosageForm

n12:PLV-SOL-INJ-INF

n3:hasPackagingSize

5

n3:hasPacking

n16:VIA

n3:hasRegistrationHolder

n13:MYSF

n3:hasRegistrationState

n15:R

n3:hasRouteOfAdministration

n18:INJ-INF

n3:hasStrength

2GM/LAH

n3:hasIndicationGroup

n19:15

n3:hasSpecializationRestriction

n10:ATB

n3:containsDefinedDailyDoses

2.5

n3:hasRegistrationCode

15/ 424/08-C

n3:hasTitleSupplement

INJ+INF PLV SOL 5X2GM

n3:containsUsualTherapeuticalDailyDoses

2.5

n3:hasBreakMarketingDate

2014-03-31+02:00

n3:hasCoreReimbursementSpecification

n9:2013-02-01 n9:2013-03-01 n9:2013-01-01 n9:2013-01-05 n9:2014-01-01 n9:2014-02-01 n9:2013-11-01 n9:2013-12-01 n9:2014-05-01 n9:2014-06-01 n9:2014-03-01 n9:2014-04-01 n9:2013-06-01 n9:2013-07-01 n9:2013-04-01 n9:2013-05-01 n9:2013-09-01 n9:2013-10-01 n9:2013-08-01 n9:2013-08-03 n9:2015-01-01 n9:2015-01-13 n9:2014-11-19 n9:2014-12-01 n9:2015-04-01 n9:2015-04-02 n9:2015-02-01 n9:2015-03-01 n9:2014-07-03 n9:2014-08-01 n9:2014-06-13 n9:2014-07-01 n9:2014-10-02 n9:2014-11-01 n9:2014-09-01 n9:2014-10-01 n9:2015-07-01 n9:2015-07-02 n9:2015-05-01 n9:2015-06-01

n3:hasPriceOfOriginatorSpecification

n11:2015-04-01 n11:2015-04-02 n11:2015-02-01 n11:2015-03-01 n11:2015-01-01 n11:2015-01-13 n11:2014-11-19 n11:2014-12-01 n11:2015-07-01 n11:2015-07-02 n11:2015-05-01 n11:2015-06-01 n11:2014-05-01 n11:2014-06-01 n11:2014-03-01 n11:2014-04-01 n11:2014-01-01 n11:2014-02-01 n11:2013-11-01 n11:2013-12-01 n11:2014-10-02 n11:2014-11-01 n11:2014-09-01 n11:2014-10-01 n11:2014-07-03 n11:2014-08-01 n11:2014-06-13 n11:2014-07-01 n11:2013-02-01 n11:2013-03-01 n11:2013-01-01 n11:2013-01-05 n11:2013-09-01 n11:2013-10-01 n11:2013-08-01 n11:2013-08-03 n11:2013-06-01 n11:2013-07-01 n11:2013-04-01 n11:2013-05-01

n3:hasPriceSpecification

n8:2014-06-13 n8:2014-07-01 n8:2014-07-03 n8:2014-08-01 n8:2014-09-01 n8:2014-10-01 n8:2014-10-02 n8:2014-11-01 n8:2014-11-19 n8:2014-12-01 n8:2015-01-01 n8:2015-01-13 n8:2015-02-01 n8:2015-03-01 n8:2015-04-01 n8:2015-04-02 n8:2013-04-01 n8:2013-05-01 n8:2013-06-01 n8:2013-07-01 n8:2013-08-01 n8:2013-08-03 n8:2013-09-01 n8:2013-10-01 n8:2013-11-01 n8:2013-12-01 n8:2014-01-01 n8:2014-02-01 n8:2014-03-01 n8:2014-04-01 n8:2014-05-01 n8:2014-06-01 n8:2013-01-01 n8:2013-01-05 n8:2013-02-01 n8:2013-03-01 n8:2015-05-01 n8:2015-06-01 n8:2015-07-01 n8:2015-07-02

n3:hasReimbursementSpecification

n14:2015-01-01 n14:2015-01-13 n14:2014-11-19 n14:2014-12-01 n14:2015-04-01 n14:2015-04-02 n14:2015-02-01 n14:2015-03-01 n14:2015-07-01 n14:2015-07-02 n14:2015-05-01 n14:2015-06-01 n14:2014-01-01 n14:2014-02-01 n14:2013-11-01 n14:2013-12-01 n14:2014-05-01 n14:2014-06-01 n14:2014-03-01 n14:2014-04-01 n14:2014-07-03 n14:2014-08-01 n14:2014-06-13 n14:2014-07-01 n14:2014-10-02 n14:2014-11-01 n14:2014-09-01 n14:2014-10-01 n14:2013-02-01 n14:2013-03-01 n14:2013-01-01 n14:2013-01-05 n14:2013-06-01 n14:2013-07-01 n14:2013-04-01 n14:2013-05-01 n14:2013-09-01 n14:2013-10-01 n14:2013-08-01 n14:2013-08-03

n3:hasResumedMarketingDate

2010-12-10+01:00

n3:hasUsualTherapeuticalDailyDose

n7:utdd

n3:spcFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC49173.pdf%26type%3Dspc%26as%3Dceftazidim-mylan-2-g-spc

n3:spcUri

n5:download.php?file=SPC49173.pdf&type=spc&as=ceftazidim-mylan-2-g-spc